129 related articles for article (PubMed ID: 16110288)
1. Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast.
Kuroda H; Sakamoto G; Ohnisi K; Itoyama S
Breast Cancer; 2005; 12(3):189-95. PubMed ID: 16110288
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast.
Ma X; Han Y; Fan Y; Cao X; Wang X
Breast J; 2014; 20(2):166-73. PubMed ID: 24400866
[TBL] [Abstract][Full Text] [Related]
3. Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases.
Hayes MM; Seidman JD; Ashton MA
Am J Surg Pathol; 1995 Aug; 19(8):904-11. PubMed ID: 7611537
[TBL] [Abstract][Full Text] [Related]
4. Fine needle aspiration cytology of glycogen-rich clear cell carcinoma of the breast: review of 37 cases with histologic correlation.
Akbulut M; Zekioglu O; Kapkac M; Erhan Y; Ozdemir N
Acta Cytol; 2008; 52(1):65-71. PubMed ID: 18323277
[TBL] [Abstract][Full Text] [Related]
5. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
[TBL] [Abstract][Full Text] [Related]
6. Clear cell carcinoma of breast lipid-rich variant.
Kini H; Bhat S; Suresh PK; Thomas M
J Cancer Res Ther; 2019; 15(5):1167-1169. PubMed ID: 31603128
[TBL] [Abstract][Full Text] [Related]
7. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
8. Glycogen-rich carcinomas of the breast display unique characteristics with respect to proliferation and the frequency of oligonucleosomal fragments.
Varga Z; Caduff R
Breast Cancer Res Treat; 1999 Sep; 57(2):215-9. PubMed ID: 10598049
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic features of invasive micropapillary carcinoma.
Kuroda H; Sakamoto G; Ohnisi K; Itoyama S
Breast Cancer; 2004; 11(2):169-74. PubMed ID: 15550863
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis.
Shafi H; Astvatsaturyan K; Chung F; Mirocha J; Schmidt M; Bose S
J Clin Pathol; 2013 Aug; 66(8):649-54. PubMed ID: 23539740
[TBL] [Abstract][Full Text] [Related]
11. [Her2-Neu expression in ductal adenocarcinomas of the breast gland: correlation with histopathological parameters and estrogen receptors' expression in Mexican patients].
Brück P; Vilches Cisneros N; Ramos López E; Barboza Quintana O; Ancer Rodríguez J; Flores Gutiérrez JP
Ginecol Obstet Mex; 2006 Oct; 74(10):516-22. PubMed ID: 21961357
[TBL] [Abstract][Full Text] [Related]
12. Cytology of glycogen-rich (clear cell) carcinoma of the breast. A report of two cases.
Kern SB; Andera L
Acta Cytol; 1997; 41(2):556-60. PubMed ID: 9100798
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Glycogen-Rich Clear Cell Carcinoma of the Breast with Extensive Intraductal Components and Micrometastases to the Axillary Lymph Node].
Seki H; Sasaki K; Morinaga S; Asanuma F; Yanaihara H; Kaneda M; Suzuki K; Ishii Y; Kamiya N; Osaku M; Ikeda T
Gan To Kagaku Ryoho; 2016 Feb; 43(2):239-41. PubMed ID: 27067690
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
15. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
[TBL] [Abstract][Full Text] [Related]
17. Fine needle aspiration cytology of glycogen-rich clear cell carcinoma of the breast. A case report.
Satoh F; Umemura S; Itoh H; Miyajima Y; Tokuda Y; Tajima T; Osamura RY
Acta Cytol; 1998; 42(2):413-8. PubMed ID: 9568148
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma.
Silver SA; Tavassoli FA
Histopathology; 2000 Jun; 36(6):505-14. PubMed ID: 10849092
[TBL] [Abstract][Full Text] [Related]
19. Glycogen Rich Clear Cell Carcinoma (GRCC) of the breast may not have a poor prognosis.
Baslaim MM; Junainah EM; Ahmad HH; Semilan AF; Al-Ghamdi AO; Rahimuddin NO; Salman BA
Int J Surg Case Rep; 2017; 33():92-96. PubMed ID: 28285212
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypes of glycogen rich clear cell carcinoma.
Kim SE; Koo JS; Jung WH
Yonsei Med J; 2012 Nov; 53(6):1142-6. PubMed ID: 23074114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
